https://www.marketscreener.com/quote/stock/EPIZYME-INC-13314771/news/Epizyme-Outlines-Clinical-Progress-TAZVERIK-Development-Strategy-and-Pipeline-Priorities-During-C-32585316/?utm_source=telegram&utm_medium=social&utm_campaign=share